[ESG 점검] 주주신뢰 회복 나선 알테오젠…핵심은 공시·거버넌스

Alteogen's transition to a data-driven ESG management framework marks a strategic shift from environmental compliance toward stakeholder transparency and investor confidence. The company's adoption of standardized data infrastructure, alongside governance reforms (audit committee, independent directors), directly responds to shareholder backlash over disclosure gaps and IR responsiveness. This demonstrates how biotech firms increasingly leverage ESG as operational infrastructure for global partnerships, where consistent non-financial reporting becomes essential for managing regulatory and partnership expectations across multiple jurisdictions.